An extensive investigation by the Madawaska Police Department, in collaboration with the Maine Drug Enforcement Agency (MDEA) ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G) Phase III study showed sustained proteinuria reduction at one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results